Michel Ollers
Overview
Explore the profile of Michel Ollers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hattu D, Mannens J, Ollers M, van Loon J, De Ruysscher D, van Elmpt W
Radiother Oncol
. 2022 Sep;
175:152-158.
PMID: 36067908
Background And Purpose: Image-guided radiotherapy using cone beam-CT (CBCT) images is used to evaluate patient anatomy and positioning before radiotherapy. In this study we analyzed and optimized a traffic light...
2.
Papoutsis I, Knudtsen I, Peter Skaug Sande E, Rekstad B, Ollers M, van Elmpt W, et al.
Phys Imaging Radiat Oncol
. 2022 Mar;
21:101-107.
PMID: 35243040
Background And Purpose: Dose painting by numbers (DPBN) require a high degree of dose modulation to fulfill the image-based voxel wise dose prescription. The aim of this study was to...
3.
De Ruysscher D, Lambrecht M, van Baardwijk A, Peeters S, Reymen B, Verhoeven K, et al.
Acta Oncol
. 2017 Aug;
56(11):1610-1613.
PMID: 28840754
No abstract available.
4.
van Loon J, Even A, Aerts H, Ollers M, Hoebers F, van Elmpt W, et al.
Radiother Oncol
. 2016 Dec;
122(2):267-273.
PMID: 28012793
Background And Purpose: PET imaging of cetuximab uptake may help selecting cancer patients with the highest chance of benefit. The aim of this phase I trial was to determine the...
5.
Martinussen H, Reymen B, Wanders R, Troost E, Dingemans A, Ollers M, et al.
Radiother Oncol
. 2016 Nov;
121(2):322-327.
PMID: 27884510
Background And Purpose: Isolated nodal failures (INF) are rare after 3D-conformal radiotherapy (3D-CRT) for stage III non-small cell lung cancer (NSCLC). Since incidental nodal irradiation doses are lower with Intensity...
6.
Knudtsen I, Svestad J, Peter Skaug Sande E, Rekstad B, Rodal J, van Elmpt W, et al.
Phys Med Biol
. 2016 Feb;
61(6):2243-54.
PMID: 26913997
Biologic image guided radiotherapy (RT) with escalated doses to tumour sub volumes challenges today's RT dose planning and delivery systems. In this phantom study, we verify the capability of a...
7.
Sharifi H, van Elmpt W, Oberije C, Nalbantov G, Das M, Ollers M, et al.
Acta Oncol
. 2015 Sep;
55(2):156-62.
PMID: 26399389
Background And Purpose: Prediction models for radiation-induced lung damage (RILD) are still unsatisfactory, with clinical toxicity endpoints that are difficult to quantify objectively. We therefore evaluated RILD more objectively, quantitatively...
8.
Van De Voorde L, Larue R, Persoon L, Ollers M, Nijsten S, Bosmans G, et al.
Radiother Oncol
. 2015 Sep;
117(3):442-7.
PMID: 26364885
Purpose: To evaluate whether adaptive radiotherapy for unaccounted stomach changes in patients with adenocarcinoma of the gastroesophageal junction (GEJ) is necessary and whether dose differences could be prevented by giving...
9.
Knudtsen I, van Elmpt W, Ollers M, Malinen E
Radiother Oncol
. 2014 Dec;
113(2):210-4.
PMID: 25443496
Purpose: In the current work, we investigate the impact of PET reconstruction methods (RMs) and threshold on two types of dose painting (DP) prescription strategies for non-small cell lung cancer...
10.
van Baardwijk A, Tome W, van Elmpt W, Bentzen S, Reymen B, Wanders R, et al.
Radiother Oncol
. 2012 Oct;
105(2):145-9.
PMID: 23068707
Background And Purpose: For stereotactic body radiotherapy (SBRT), typically a scheme of 60 Gy in 3-8 fractions is applied, producing local tumour control rates around 90%. The dose specification is...